e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Comorbidities of idiopathic pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Subtypes of lung adenocarcinomas associated with IPF
G. Gomatou (Athens, Greece), R. Tringidou (Athens, Greece), T. Karampitsakos (Athens, Greece), V. Tzilas (Athens, Greece), A. Tzouvelekis (Athens, Greece), D. Bouros (Athens, Greece)
Source:
International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Session:
Comorbidities of idiopathic pulmonary fibrosis
Session type:
Thematic Poster
Number:
1310
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Gomatou (Athens, Greece), R. Tringidou (Athens, Greece), T. Karampitsakos (Athens, Greece), V. Tzilas (Athens, Greece), A. Tzouvelekis (Athens, Greece), D. Bouros (Athens, Greece). Subtypes of lung adenocarcinomas associated with IPF. 1310
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Immunophenotypic profiles of lung carcinomas associated with idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
Coexistence of COPD in lung cancer patients
Source: Eur Respir J 2001; 18: Suppl. 33, 66s
Year: 2001
MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD
Source: Eur Respir J 2014; 43: 1740-1749
Year: 2014
Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease.
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021
Epigenetics in IPF and lung cancer
Source: Research Seminar 2015
Year: 2015
Treatment and prognosis of lung cancer associated with interstitial pneumonia
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010
The prevalence of bronchogenic lung cancer (BLC) in patients with idiopathic pneumonic fibrosis (IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 250s
Year: 2003
Lung cancer and interstitial lung disease
Source: International Congress 2018 – State of the art session: Thoracic oncology
Year: 2018
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005
Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018
Distinct forms of BARD1 expressed in lung fibrosis and lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 325s
Year: 2006
Non-small cell lung cancer resected molecular expression in COPD and low function pulmonary patients
Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies
Year: 2007
Lung cancer as a comorbidity in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases
Year: 2012
PP131 – Macrophages in lung adenocarcinoma
Source: ERS Lung Science Conference 2021
Year: 2021
Analysis of the mucus properties in smokers with lung cancer or extra-pulmonary cancer and non smokers with pulmonary metastasis
Source: Eur Respir J 2006; 28: Suppl. 50, 656s
Year: 2006
The association of lung cancer with pulmonary fibrosis
Source: ERJ Open Res, 8 (1) 00505-2021; 10.1183/23120541.00505-2021
Year: 2022
Angiogenesis in bronchial biopsies of symptomatic smokers with and without lung cancer
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
How to treat lung cancer in IPF patients
Source: Research Seminar 2015
Year: 2015
COPD as an independent risk factor for lung cancer in patients with bronchial squamous dysplasia
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Multiple carcinomas in the lung cancer patients
Source: Eur Respir J 2007; 30: Suppl. 51, 671s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept